This site uses cookies to ensure the best viewing experience for our readers.
Medical Cannabis Company Together Plans to List Subsidiary Cannabliss in North America

Medical Cannabis Company Together Plans to List Subsidiary Cannabliss in North America

Cannabliss develops and manufactures smoke-free cannabis products, such as oils, candies, and cookies

Tzally Greenberg  :  2019-09-15T12:43:03..
Tel Aviv-listed medical cannabis company Together Pharma Ltd. is planning to list its wholly owned subsidiary Cannabliss Ltd., the company announced Sunday. The company is planning a North American initial public offering at a company valuation of between $40 million and $50 million, with the roadshow scheduled for the first quarter of 2020, one person familiar with the matter told Calcalist on condition of anonymity. Together has a market capitalization of around $44.9 million.

Founded in 2009, Cannabliss develops and manufactures smoke-free cannabis products, such as oils, candies, and cookies. The company maintains a research and development cooperation agreement as well as a distribution center in conjunction with the Hadassah Ein Kerem hospital in Jerusalem. Together acquired the company in June for NIS 14 million (nearly $4 million).

Medical cannabis. Photo: Shutterstock Medical cannabis. Photo: Shutterstock Medical cannabis. Photo: Shutterstock

As part of the preparation for the IPO, Together also announced Sunday that Citrine Cannabis GP of the Citrine Investment Group and Israeli accelerator and services company iCAN: Israel-Cannabis will make a joint investment of $900,000 in Cannabliss according to a company valuation of NIS 20 million ($5.67 million), in return for a 15% stake in the company.

share on facebook share on twitter share on linkedin share on whatsapp share on mail

TAGS